(Q51988004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Rosa Coppola

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

14

Tommaso Stroffolini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Alessandro Remo Zanetti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Andrea Mariano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Luisa Romanò

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Raffaele D'Amelio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Mario Cuccia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Rossana Mangione

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Fosca Marrone

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Francesco Saverio Negrone

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Antonino Parlato

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Emanuela Zamparo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Carla Zotti

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alfonso Mele

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Study Group

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

9494

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

1379-1384

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

Global status of hepatitis B immunisation

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Vaccines to prevent viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Mass vaccination against hepatitis B in infants in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Vaccination against hepatitis B: the Italian strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Long-term protection of hepatitis B vaccine: lessons from Alaskan experience after 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Update on hepatitis B vaccination in Italy 10 years after its implementation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Prevention of viral hepatitis in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Chronic hepatitis D: a vanishing Disease? An Italian multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967568-X

7 January 2021

10.1016/S0140-6736(05)67568-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16226616%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference